...
首页> 外文期刊>Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences >Simultaneous determination of niacin and its metabolites--nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide--in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
【24h】

Simultaneous determination of niacin and its metabolites--nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide--in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

机译:LC-MS / MS同时测定人血浆中烟酸及其代谢物-烟酰胺,烟酸和N-甲基-2-吡啶酮-5-羧酰胺及其在人体药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

An LC-MS/MS method for the simultaneous quantitation of niacin (NA) and its metabolites, i.e. nicotinamide (NAM), nicotinuric acid (NUA) and N-methyl-2-pyridone-5-carboxamide (2-Pyr), in human plasma (1 mL) was developed and validated using nevirapine as an internal standard (IS). Extraction of the NA and its metabolites along with the IS from human plasma was accomplished using a simple liquid-liquid extraction. The chromatographic separation of NA, NAM, NUA, 2-Pyr and IS was achieved on a Hypersil-BDS column (150 x 4.6 mm, 5 microm) column using a mobile phase consisting of 0.1% formic acid : acetonitrile (20:80 v/v) at a flow rate of 1 mL/min. The total run time of analysis was 2 min and elution of NA, NAM, NUA, 2-Pyr and IS occurred at 1.37, 1.46, 1.40, 1.06 and 1.27 min, respectively. A detailed validation of the method was performed as per the FDA guidelines and the standard curves were found to be linear in the range of 100-20000 ng/mL for NA; 10-1600 ng/mL for NUA and NAM and 50-5000 ng/mL for 2-Pyr with mean correlation coefficient of >/= 0.99 for each analyte. The method was sensitive, specific, precise, accurate and suitable for bioequivalence and pharmacokinetic studies. The developed assay method was successfully applied to a pharmacokinetic study in humans.
机译:LC-MS / MS方法同时测定烟酸中的烟酸(NA)及其代谢物,即烟酰胺(NAM),烟酸(NUA)和N-甲基-2-吡啶酮-5-甲酰胺(2-Pyr)使用奈韦拉平作为内标(IS)开发并验证了人类血浆(1 mL)。使用简单的液-液提取可以完成从人血浆中提取NA及其代谢物以及IS的操作。 NA,NAM,NUA,2-Pyr和IS的色谱分离是在Hypersil-BDS色谱柱(150 x 4.6 mm,5微米)上进行的,流动相为0.1%甲酸:乙腈(20:80 v / v)的流速为1 mL / min。分析的总运行时间为2分钟,NA,NAM,NUA,2-Pyr和IS的洗脱时间分别为1.37、1.46、1.40、1.06和1.27分钟。根据FDA指南对该方法进行了详细的验证,发现NA的标准曲线在100-20000 ng / mL范围内是线性的。 NUA和NAM为10-1600 ng / mL,2-Pyr为50-5000 ng / mL,每种分析物的平均相关系数> / = 0.99。该方法灵敏,特异,精确,准确,适用于生物等效性和药代动力学研究。所开发的测定方法已成功地应用于人体的药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号